Search results
GSK (LON:GSK) Given Underweight Rating at JPMorgan Chase & Co.
ETF DAILY NEWS· 5 days agoJPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com ...
iTeos Therapeutics and GSK begin Phase III trial of combination therapy for NSCLC
Clinical Trials Arena via Yahoo Finance· 6 days agoiTeos Therapeutics and GSK have begun the GALAXIES Lung-301 Phase III clinical trial of belrestotug...
Industry Groups Back Drugmakers' Appeal in Zantac Cancer Lawsuits
Insurance Journal· 4 days agoA bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - Innoviva (NASDAQ:INVA)
Benzinga· 5 days agoCantor Fitzgerald has initiated coverage on Innoviva, Inc. INVA, citing the company’s unique...
Major drug companies cap asthma medication costs at $35 per month
WISN 12 Milwaukee· 2 days agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoPublished exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1212 ET – GSK is betting on AI to boost innovation for its pipeline as...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks· 5 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face the FDA's partial clinical hold following the death of two patients.
As big pharma exits Nigeria, asthma patients face spiralling costs
Al Jazeera· 5 days agoWhen Gloria Mofifoluwa’s friend informed her in March that the price of inhalers had risen in...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoFind insight on GSK, Top Glove, ResMed and more in the latest Market Talks covering the Health Care sector.
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 2 days agoSeveral studies presented at the congress, including DREAMM-8, LINKER-MM1, and GMMG-HD7, highlighted...